Mesoblast Limited (ASX:MSB)
2.400
-0.090 (-3.61%)
Sep 26, 2025, 4:10 PM AEST
Mesoblast Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Revenue | 17.2 | 5.9 | 7.5 | 10.21 | 7.43 | Upgrade
|
Revenue Growth (YoY) | 191.39% | -21.32% | -26.54% | 37.35% | -76.88% | Upgrade
|
Cost of Revenue | 39.94 | 39.72 | 52.82 | 63.57 | 85.73 | Upgrade
|
Gross Profit | -22.74 | -33.81 | -45.32 | -53.36 | -78.3 | Upgrade
|
Selling, General & Admin | 39.31 | 24.98 | 27.48 | 27.21 | 30.87 | Upgrade
|
Other Operating Expenses | 0.4 | -0.82 | -3.51 | 0 | -0.07 | Upgrade
|
Operating Expenses | 39.7 | 24.16 | 23.97 | 27.21 | 30.8 | Upgrade
|
Operating Income | -62.44 | -57.97 | -69.29 | -80.57 | -109.1 | Upgrade
|
Interest Expense | -21.75 | -20.66 | -19.44 | -16.91 | -15.94 | Upgrade
|
Interest & Investment Income | 3.55 | 1.82 | 0.83 | 0 | 0.02 | Upgrade
|
Currency Exchange Gain (Loss) | -0.11 | -0.08 | -0.16 | -0.54 | 1.47 | Upgrade
|
Other Non Operating Income (Expenses) | -6.18 | -1.57 | -2.88 | 5.51 | 5.23 | Upgrade
|
EBT Excluding Unusual Items | -86.93 | -78.45 | -90.95 | -92.5 | -118.32 | Upgrade
|
Asset Writedown | - | - | 0.08 | - | - | Upgrade
|
Other Unusual Items | -14.89 | -9.69 | 8.77 | 0.91 | 18.69 | Upgrade
|
Pretax Income | -101.81 | -88.15 | -82.1 | -91.59 | -99.63 | Upgrade
|
Income Tax Expense | 0.33 | -0.19 | -0.21 | -0.24 | -0.82 | Upgrade
|
Net Income | -102.14 | -87.96 | -81.89 | -91.35 | -98.81 | Upgrade
|
Net Income to Common | -102.14 | -87.96 | -81.89 | -91.35 | -98.81 | Upgrade
|
Shares Outstanding (Basic) | 1,208 | 987 | 778 | 683 | 605 | Upgrade
|
Shares Outstanding (Diluted) | 1,208 | 987 | 778 | 683 | 605 | Upgrade
|
Shares Change (YoY) | 22.41% | 26.87% | 13.89% | 12.86% | 14.42% | Upgrade
|
EPS (Basic) | -0.08 | -0.09 | -0.11 | -0.13 | -0.16 | Upgrade
|
EPS (Diluted) | -0.08 | -0.09 | -0.11 | -0.13 | -0.16 | Upgrade
|
Free Cash Flow | -50.63 | -48.73 | -63.53 | -65.94 | -102.4 | Upgrade
|
Free Cash Flow Per Share | -0.04 | -0.05 | -0.08 | -0.10 | -0.17 | Upgrade
|
Gross Margin | -132.22% | - | - | - | - | Upgrade
|
Operating Margin | -363.08% | -982.24% | -923.73% | -789.09% | -1467.53% | Upgrade
|
Profit Margin | -593.92% | -1490.27% | -1091.71% | -894.59% | -1329.18% | Upgrade
|
Free Cash Flow Margin | -294.42% | -825.63% | -846.99% | -645.76% | -1377.40% | Upgrade
|
EBITDA | -58.18 | -56.08 | -66.84 | -77.91 | -106.52 | Upgrade
|
D&A For EBITDA | 4.26 | 1.9 | 2.45 | 2.66 | 2.57 | Upgrade
|
EBIT | -62.44 | -57.97 | -69.29 | -80.57 | -109.1 | Upgrade
|
Revenue as Reported | 17.2 | 5.9 | 7.5 | - | - | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.